
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer stem cell (CSC) resistance drivers
Masoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences (2019) Vol. 234, pp. 116781-116781
Closed Access | Times Cited: 379
Masoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences (2019) Vol. 234, pp. 116781-116781
Closed Access | Times Cited: 379
Showing 1-25 of 379 citing articles:
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1143
Lei Zhong, Yueshan Li, Liang Xiong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1143
Nanomaterials for cancer therapy: current progress and perspectives
Zhe Cheng, Maoyu Li, Raja Dey, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 846
Zhe Cheng, Maoyu Li, Raja Dey, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 846
Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4002-4002
Open Access | Times Cited: 219
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4002-4002
Open Access | Times Cited: 219
Steps in metastasis: an updated review
Jamal Majidpoor, Keywan Mortezaee
Medical Oncology (2021) Vol. 38, Iss. 1
Closed Access | Times Cited: 213
Jamal Majidpoor, Keywan Mortezaee
Medical Oncology (2021) Vol. 38, Iss. 1
Closed Access | Times Cited: 213
Engineered exosomes from different sources for cancer-targeted therapy
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 198
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 198
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 177
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 177
Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
Julia López de Andrés, Carmen Griñán‐Lisón, Gema Jiménez, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 162
Julia López de Andrés, Carmen Griñán‐Lisón, Gema Jiménez, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 162
Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective
Jiyou Han, Miae Won, Ji Hyeon Kim, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 22, pp. 7856-7878
Closed Access | Times Cited: 154
Jiyou Han, Miae Won, Ji Hyeon Kim, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 22, pp. 7856-7878
Closed Access | Times Cited: 154
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
Shujing Wang, Jingrui Wang, Zhiqiang Chen, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 148
Shujing Wang, Jingrui Wang, Zhiqiang Chen, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 148
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 138
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 138
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 137
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 137
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 131
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 131
Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
Caitlin M. Tilsed, Scott Fisher, Anna K. Nowak, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 96
Caitlin M. Tilsed, Scott Fisher, Anna K. Nowak, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 96
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Characteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju, Manar Atyah, Nellie Horstmann, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Feng Ju, Manar Atyah, Nellie Horstmann, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance
Nasim Ebrahimi, Maral Afshinpour, Siavash Seifollahy Fakhr, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 182, pp. 103920-103920
Open Access | Times Cited: 62
Nasim Ebrahimi, Maral Afshinpour, Siavash Seifollahy Fakhr, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 182, pp. 103920-103920
Open Access | Times Cited: 62
Emerging roles of Aurora-A kinase in cancer therapy resistance
Dayong Zheng, Jun Li, Han Yan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 7, pp. 2826-2843
Open Access | Times Cited: 44
Dayong Zheng, Jun Li, Han Yan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 7, pp. 2826-2843
Open Access | Times Cited: 44
NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score
Liusheng Wu, Xiaofan Chen, Qi Zeng, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28282-e28282
Open Access | Times Cited: 36
Liusheng Wu, Xiaofan Chen, Qi Zeng, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28282-e28282
Open Access | Times Cited: 36
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
The tumor microenvironment: a key player in multidrug resistance in cancer
Lingnan Meng, Ying Zheng, Hao Liu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 1, pp. 41-58
Open Access | Times Cited: 18
Lingnan Meng, Ying Zheng, Hao Liu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 1, pp. 41-58
Open Access | Times Cited: 18
Oxidative Stress and Age-Related Tumors
Emma Di Carlo, Carlo Sorrentino
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1109-1109
Open Access | Times Cited: 17
Emma Di Carlo, Carlo Sorrentino
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1109-1109
Open Access | Times Cited: 17
Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 6
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 6
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Yixiang Gu, Ruifeng Yang, Yang Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Yixiang Gu, Ruifeng Yang, Yang Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 6